Btissame El Hassouni

20182019
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2019

  • 5 Article
  • 1 Comment/Letter to the editor
  • 1 Review article
2019

Pharmacogenetics of treatments for pancreatic cancer

el Hassouni, B., Li Petri, G., Liu, D. S. K., Cascioferro, S., Parrino, B., Hassan, W., Diana, P., Ali, A., Frampton, A. E. & Giovannetti, E., 2019, In : Expert Opinion on Drug Metabolism and Toxicology. 15, 6, p. 437-447

Research output: Contribution to journalArticleAcademicpeer-review

Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells

Firuzi, O., Che, P. P., el Hassouni, B., Buijs, M., Coppola, S., Löhr, M., Funel, N., Heuchel, R., Carnevale, I., Schmidt, T., Mantini, G., Avan, A., Saso, L., Peters, G. J. & Giovannetti, E., 2019, In : Cancers. 11, 5, 638.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment

Balboni, B., el Hassouni, B., Honeywell, R. J., Sarkisjan, D., Giovannetti, E., Poore, J., Heaton, C., Peterson, C., Benaim, E., Lee, Y. B., Kim, D. J. & Peters, G. J., 2019, In : Expert Opinion on Investigational Drugs. 28, 4, p. 311-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Sciarrillo, R., Wojtuszkiewicz, A., El Hassouni, B., Funel, N., Gandellini, P., Lagerweij, T., Buonamici, S., Blijlevens, M., Zeeuw van der Laan, E. A., Zaffaroni, N., Deraco, M., Kusamura, S., Würdinger, T., Peters, G. J., Molthoff, C. F. M., Jansen, G., Kaspers, G. J. L., Cloos, J. & Giovannetti, E., Jan 2019, In : EBioMedicine. 39, p. 215-225

Research output: Contribution to journalArticleAcademicpeer-review

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

EORTC PAMM Group, Jul 2019, In : Anticancer Research. 39, 7, p. 3303-3309 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2018

Multidrug-resistant transporter expression does not always result in drug resistance

le Large, T. Y. S., el Hassouni, B., Kazemier, G., Piersma, S. R., van Laarhoven, H. W. M., Bijlsma, M. F., Jimenez, C. R. & Giovannetti, E., 2018, In : Cancer Science. 109, 10, p. 3360-3362 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance

El Hassouni, B., Sarkisjan, D., Vos, J. C., Giovannetti, E. & Peters, G. J., 3 Dec 2018, In : Current Medicinal Chemistry.

Research output: Contribution to journalArticleAcademicpeer-review